<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32204528</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1420-3049</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>19</Day></PubDate></JournalIssue><Title>Molecules (Basel, Switzerland)</Title><ISOAbbreviation>Molecules</ISOAbbreviation></Journal><ArticleTitle>Antiviral Effects of Novel 2-Benzoxyl-Phenylpyridine Derivatives.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1409</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules25061409</ELocationID><Abstract><AbstractText>Coxsackievirus B3 (CVB3) is the most common cause of acute and chronic viral myocarditis, primarily in children, while human adenovirus infections represent a significant cause of morbidity and mortality worldwide, in people of all ages. A series of novel 2-benzoxyl-phenylpyridine derivatives were evaluated for their potential antiviral activities against CVB3 and adenovirus type 7 (ADV7). Preliminary assays indicated that some of these compounds exhibited excellent antiviral effects on both CVB3 and ADV7 viruses; they could effectively inhibit virus-induced cytopathic effects, reduce viral progeny yields, and had similar or superior antiviral activities compared with the control drug, ribavirin. Further, these compounds targeted the early stages of CVB3 replication in cells, including viral RNA replication and protein synthesis, rather than inactivating the virus directly, inhibiting virus adsorption/entry, or affecting viral release from cells. Our data demonstrate that the tested 2-benzoxyl-phenylpyridine derivatives are effective inhibitors of CVB3 and ADV7, raising the possibility that these compounds might be feasible candidates for anti-viral agents.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Yanhong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Hubei Key Laboratory of Industrial Microbiology, Sino-German Biomedical Center, School of Materials and Chemical Engineering, Hubei University of Technology, Wuhan 430068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Haijie</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Hubei Key Laboratory of Industrial Microbiology, Sino-German Biomedical Center, School of Materials and Chemical Engineering, Hubei University of Technology, Wuhan 430068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xi</LastName><ForeName>Caili</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Hubei Key Laboratory of Industrial Microbiology, Sino-German Biomedical Center, School of Materials and Chemical Engineering, Hubei University of Technology, Wuhan 430068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ni</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Hubei Key Laboratory of Industrial Microbiology, Sino-German Biomedical Center, School of Materials and Chemical Engineering, Hubei University of Technology, Wuhan 430068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Dong</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-1246-1926</Identifier><AffiliationInfo><Affiliation>School of Materials and Chemical Engineering, Hubei University of Technology, Wuhan 430068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Chenguang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Hubei Key Laboratory of Industrial Microbiology, Sino-German Biomedical Center, School of Materials and Chemical Engineering, Hubei University of Technology, Wuhan 430068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Ge</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Hubei Key Laboratory of Industrial Microbiology, Sino-German Biomedical Center, School of Materials and Chemical Engineering, Hubei University of Technology, Wuhan 430068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ge</LastName><ForeName>Hongmei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Hubei Key Laboratory of Industrial Microbiology, Sino-German Biomedical Center, School of Materials and Chemical Engineering, Hubei University of Technology, Wuhan 430068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Kanghong</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>National "111" Center for Cellular Regulation and Molecular Pharmaceutics, Key Laboratory of Fermentation Engineering (Ministry of Education), Hubei Provincial Cooperative Innovation Center of Industrial Fermentation, Hubei Key Laboratory of Industrial Microbiology, Sino-German Biomedical Center, School of Materials and Chemical Engineering, Hubei University of Technology, Wuhan 430068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>School of Materials and Chemical Engineering, Hubei University of Technology, Wuhan 430068, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>XBTK-2018005</GrantID><Agency>the Collaborative Grant-in-Aid of the HBUT National "111" Center for Cellular Regulation and Molecular Pharmaceutics</Agency><Country/></Grant><Grant><GrantID>BSQD2015004</GrantID><Agency>the Doctoral Scientific Research Foundation of Hubei University of Technology</Agency><Country/></Grant><Grant><GrantID>31400153</GrantID><Agency>the National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>31800457</GrantID><Agency>the National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>03</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Molecules</MedlineTA><NlmUniqueID>100964009</NlmUniqueID><ISSNLinking>1420-3049</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011725">Pyridines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000260" MajorTopicYN="N">Adenoviruses, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011725" MajorTopicYN="N">Pyridines</DescriptorName><QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053586" MajorTopicYN="N">Virus Internalization</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">2-benzoxyl-phenylpyridine derivatives</Keyword><Keyword MajorTopicYN="N">ADV7</Keyword><Keyword MajorTopicYN="N">CVB3</Keyword><Keyword MajorTopicYN="N">antiviral activity</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2020</Year><Month>3</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32204528</ArticleId><ArticleId IdType="pmc">PMC7144376</ArticleId><ArticleId IdType="doi">10.3390/molecules25061409</ArticleId><ArticleId IdType="pii">molecules25061409</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Massilamany C., Gangaplara A., Reddy J. Intricacies of cardiac damage in coxsackievirus B3 infection: Implications for therapy. Int. J. Cardiol. 2014;177:330&#x2013;339. doi: 10.1016/j.ijcard.2014.09.136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2014.09.136</ArticleId><ArticleId IdType="pmc">PMC4403007</ArticleId><ArticleId IdType="pubmed">25449464</ArticleId></ArticleIdList></Reference><Reference><Citation>Garmaroudi F.S., Marchant D., Hendry R., Luo H., Yang D., Ye X., Shi J., McManus B.M. Coxsackievirus B3 replication and pathogenesis. Future Microbiol. 2015;10:629&#x2013;653. doi: 10.2217/fmb.15.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.15.5</ArticleId><ArticleId IdType="pubmed">25865198</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber S., Ramsingh A.I. Coxsackievirus-induced pancreatitis. Viral Immunol. 2004;17:358&#x2013;369. doi: 10.1089/vim.2004.17.358.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2004.17.358</ArticleId><ArticleId IdType="pubmed">15357902</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemball C.C., Flynn C.T., Hosking M.P., Botten J., WhittonJ L. Wild-type coxsackievirus infection dramatically alters the abundance, heterogeneity, and immunostimulatory capacity of conventional dendritic cells in vivo. Virology. 2012;429:74&#x2013;90. doi: 10.1016/j.virol.2012.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2012.04.005</ArticleId><ArticleId IdType="pmc">PMC3358485</ArticleId><ArticleId IdType="pubmed">22551767</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni H.X., Yi B., Yin J.H., Fang T., He T.F., Du Y., Wang J., Zhang H.W., Xie L., Ding Y.B., et al. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Ningbo, China, 2008&#x2013;2011. J. Clin. Virol. 2012;54:342&#x2013;348. doi: 10.1016/j.jcv.2012.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2012.04.021</ArticleId><ArticleId IdType="pubmed">22652041</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J.Y., Jeong H.I., Park C.W., Yoon J., Ko J., Nam S.J., Lim B.K. Cholic Acid Attenuates ER Stress-Induced Cell Death in Coxsackievirus-B3 Infection. J. Microbiol. Biotechnol. 2018;28:109&#x2013;114. doi: 10.4014/jmb.1708.08009.</Citation><ArticleIdList><ArticleId IdType="doi">10.4014/jmb.1708.08009</ArticleId><ArticleId IdType="pubmed">29032641</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.Y., Li J.Y., Xia H.H.X., Zhang S.L., Zhong J., Wu Y.Y., Miao S.K., Zhou L.M. Protective effects of losartan in mice with chronic viral myocarditis induced by coxsackievirus B3. Life Sci. 2013;92:1186&#x2013;1194. doi: 10.1016/j.lfs.2013.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2013.05.010</ArticleId><ArticleId IdType="pubmed">23702425</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B.K., Kim J.H., Kim N.R., Lee W.G., Lee S.D., Yun S.H., Jeon E.S., Kim Y.C. Development of anti-coxsackievirus agents targeting 3C protease. Bioorg. Med. Chem. Lett. 2012;22:6952&#x2013;6956. doi: 10.1016/j.bmcl.2012.08.120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2012.08.120</ArticleId><ArticleId IdType="pubmed">23062551</ArticleId></ArticleIdList></Reference><Reference><Citation>Fechner H., Pinkert S., Geisler A., Poller W., Kurreck J. Pharmacological and biological antiviral therapeutics for cardiac coxsackievirus infections. Molecules. 2011;16:8475&#x2013;8503. doi: 10.3390/molecules16108475.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules16108475</ArticleId><ArticleId IdType="pmc">PMC6264230</ArticleId><ArticleId IdType="pubmed">21989310</ArticleId></ArticleIdList></Reference><Reference><Citation>Thibaut H.J., De Palma A.M., Neyts J. Combating enterovirus replication: State-of-the-art on antiviral research. Biochem. Pharmacol. 2012;83:185&#x2013;192. doi: 10.1016/j.bcp.2011.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2011.08.016</ArticleId><ArticleId IdType="pubmed">21889497</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu F.Z., Shen X.X., Li G.X., Zhao L., Chen C., Duan S.X., Guo J.Y., Zhao M.C., Yan T.F., Qi J.J., et al. Adenovirus associated with acute diarrhea: A case-control study. BMC Infect. Dis. 2018;18:450. doi: 10.1186/s12879-018-3340-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-018-3340-1</ArticleId><ArticleId IdType="pmc">PMC6122197</ArticleId><ArticleId IdType="pubmed">30176819</ArticleId></ArticleIdList></Reference><Reference><Citation>Engelmann I., Coiteux V., Heim A., Magro L., Dewilde A., Dulery R., Hober D., Yakoub-Agha I. Severe adenovirus pneumonia followed by bacterial septicaemia: Relevance of co-infections in allogeneic hematopoietic stem cell transplantation. Infect. Disord. Drug Targets. 2016;16:69&#x2013;76. doi: 10.2174/1871526516666160407114623.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871526516666160407114623</ArticleId><ArticleId IdType="pubmed">27052333</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan D.Y., Zhu H.D., Fu Y.Y., Tong F., Yao D.Q., Walline J., Xu J., Yu X.Z. Severe community-acquired pneumonia caused by human adenovirus in immunocompetent adults: A multicenter case series. PLoS ONE. 2016;11:e0151199. doi: 10.1371/journal.pone.0151199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0151199</ArticleId><ArticleId IdType="pmc">PMC4788423</ArticleId><ArticleId IdType="pubmed">26967644</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S.Y., Luo Y.P., Huang D.D., Fan H., Lu Q.B., Wo Y., Chen G., Zhang X.A., Li Y., Tong Y.G., et al. Fatal pneumonia cases caused by human adenovirus 55 in immunocompetent adults. Infect. Dis. 2015;48:40&#x2013;47. doi: 10.3109/23744235.2015.1055585.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/23744235.2015.1055585</ArticleId><ArticleId IdType="pubmed">26465201</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie L.Y., Zhang B., Xiao N.G., Zhang F., Zhao X., Liu Q., Xie Z.P., Gao H.C., Duan Z.J., Zhong L.L. Epidemiology of human adenovirus infection in children hospitalized with lower respiratory tract infections in Hunan, China. J. Med. Virol. 2018;91:392&#x2013;400. doi: 10.1002/jmv.25333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25333</ArticleId><ArticleId IdType="pmc">PMC7159165</ArticleId><ArticleId IdType="pubmed">30286268</ArticleId></ArticleIdList></Reference><Reference><Citation>De Clercq E. The clinical potential of the acyclic(and cyclic)nucleoside phosphonates: The magic of the phosphonate bond. Biochem. Pharmacol. 2011;82:99&#x2013;109. doi: 10.1016/j.bcp.2011.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2011.03.027</ArticleId><ArticleId IdType="pubmed">21501598</ArticleId></ArticleIdList></Reference><Reference><Citation>Hostetler K.Y. Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: Current state of the art. Antivir. Res. 2009;82:A84&#x2013;A98. doi: 10.1016/j.antiviral.2009.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2009.01.005</ArticleId><ArticleId IdType="pmc">PMC2768545</ArticleId><ArticleId IdType="pubmed">19425198</ArticleId></ArticleIdList></Reference><Reference><Citation>Naesens L., Lenaerts L., Andrei G., Snoeck R., Van Beers D., Holy A., Balzarini J., De Clercq E. Antiadenovirus activities of several classes of nucleoside and nucleotide analogues. Antimicrob. Agents Chemother. 2005;49:1010&#x2013;1016. doi: 10.1128/AAC.49.3.1010-1016.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.49.3.1010-1016.2005</ArticleId><ArticleId IdType="pmc">PMC549266</ArticleId><ArticleId IdType="pubmed">15728896</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Z.Z., Zang N., Fu Y.X., Ye Z.X., Chen S.S., Mo S., Ren L., Liu E. HMGB1 mediates HADV7 infection-induced pulmonary inflammation in mice. Biochem. Biophys. Res. Commun. 2018;501:1&#x2013;8. doi: 10.1016/j.bbrc.2018.03.145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2018.03.145</ArticleId><ArticleId IdType="pubmed">29571731</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xc1; A.G.A., de Meneses A.C., de Ara&#xfa;jo P.H.H., de Oliveira D. A review on enzymatic synthesis of aromatic esters used as flavor ingredients for food, cosmetics and pharmaceuticals industries. Trends Food Sci. Technol. 2017;69:95&#x2013;105. doi: 10.1016/j.tifs.2017.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tifs.2017.09.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams T.B., Cohen S.M., Doull J., Feron V.J. The FEMA GRAS assessment of benzyl derivatives used as flavor ingredients. Food Chem. Toxicol. 2005;43:1207&#x2013;1240. doi: 10.1016/j.fct.2004.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2004.11.014</ArticleId><ArticleId IdType="pubmed">15950815</ArticleId></ArticleIdList></Reference><Reference><Citation>US Food and Drug Administration Food additives permitted for direct addition to food for human consumption, flavoring agents and related substances. Code Fed. Regul. 2011:515.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>JECFA  Safety Evaluation of Certain Food Additives and Contaminants: Prepared by the Seventy Seventh Meeting of the Joint FAO/WHO Ex-pert Committee on Food Additives (JECFA)  [(accessed on 18 May 2006)];2007  Available online:  http://apps.who.int/iris/bitstream/10665/43645/1/9789241660587_eng.pdf.</Citation></Reference><Reference><Citation>Pavela R. Essential oils for the development of eco-friendly mosquito larvicides: A review. Ind. Crop. Prod. 2015;76:174&#x2013;187. doi: 10.1016/j.indcrop.2015.06.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.indcrop.2015.06.050</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Wang Y., Yang T.T., Li L., Li D. Palladium catalyzed ortho-C&#x2013;H-benzoxylation of 2-arylpyridines using iodobenzene dibenzoates. Tetrahedron Lett. 2015;56:6136&#x2013;6141. doi: 10.1016/j.tetlet.2015.09.097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tetlet.2015.09.097</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B.-K., Cho J.-H., Jeong P., Lee Y., Lim J.J., Park K.R., Eom S.H., Kim Y.-C. Benserazide, the first allosteric inhibitor of Coxsackievirus B3 3C protease. FEBS Lett. 2015;589:1795&#x2013;1801. doi: 10.1016/j.febslet.2015.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2015.05.027</ArticleId><ArticleId IdType="pmc">PMC7094222</ArticleId><ArticleId IdType="pubmed">26022398</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoeben R.C., Uil T.G. Adenovirus DNA Replication. Cold Spring Harb Perspect. Biol. 2013;5:a013003. doi: 10.1101/cshperspect.a013003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a013003</ArticleId><ArticleId IdType="pmc">PMC3578361</ArticleId><ArticleId IdType="pubmed">23388625</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrugal-Lorenzo J.A., Serna-Gallego A., Berastegui-Cabrera J., Pach&#xf3;n J., S&#xe1;nchez-C&#xe9;spedes J. Repositioning Salicylanilide Anthelmintic Drugs to Treat Adenovirus Infections. Sci. Rep. 2019;9:17. doi: 10.1038/s41598-018-37290-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-37290-3</ArticleId><ArticleId IdType="pmc">PMC6327057</ArticleId><ArticleId IdType="pubmed">30626902</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong D.W., Liu M.M., Cao Y., Zhu Y.L., Bian S.H., Zhou J.Y., Wu F.J., Ryu K.C., Zhou L., Ye D.Y. Discovery of Metal Ions Chelator Quercetin Derivatives with Potent Anti-HCV Activities. Molecules. 2015;20:6978&#x2013;6999. doi: 10.3390/molecules20046978.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules20046978</ArticleId><ArticleId IdType="pmc">PMC6272327</ArticleId><ArticleId IdType="pubmed">25913935</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchiya Y., Shimizu M., Hiyama Y., Itoh K., Hashimoto Y., Nakayama M., Horie T., Morita N. Antiviral activity of natural occurring flavonoids in vitro. Chem. Pharm. Bull. 1985;33:3881&#x2013;3886. doi: 10.1248/cpb.33.3881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/cpb.33.3881</ArticleId><ArticleId IdType="pubmed">4092287</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T.C., Weng K.F., Chang S.C., Lin J.Y., Huang P.N., Shih S.R. Development of antiviral agents for enteroviruses. J. Antimicrob. Chemother. 2008;62:1169&#x2013;1173. doi: 10.1093/jac/dkn424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkn424</ArticleId><ArticleId IdType="pubmed">18931391</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedard K.M., Semler B.L. Regulation of picornavirus gene expression. Microbes Infect. 2004;6:702&#x2013;713. doi: 10.1016/j.micinf.2004.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2004.03.001</ArticleId><ArticleId IdType="pubmed">15158778</ArticleId></ArticleIdList></Reference><Reference><Citation>Farkas T., Yang K., Le Pendu J., Baines J.D., Cardin R.D. The Coxsackievirus and Adenovirus Receptor, a Required Host Factor for Recovirus Infection, Is a Putative Enteric Calicivirus Receptor. J. Virol. 2019;93 doi: 10.1128/JVI.00869-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00869-19</ArticleId><ArticleId IdType="pmc">PMC6819923</ArticleId><ArticleId IdType="pubmed">31484750</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitazato K., Wang Y., Kobayashi N. Viral infectious disease and natural products with antiviral activity. Drug Discov. Ther. 2007;1:14&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">22504360</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosso F., Stoilov P., Lingwood C., Brown M., Cochrane A. Suppression of Adenovirus Replication by Cardiotonic Steroids. J. Virol. 2017;91:e01623-16. doi: 10.1128/JVI.01623-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01623-16</ArticleId><ArticleId IdType="pmc">PMC5244322</ArticleId><ArticleId IdType="pubmed">27881644</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.H., Tang S., Li Y.H., Cheng X.Y., Zhang X., Wang Y.X., Su F., Song D.Q. Novel 12N-substituted matrinanes as potential anti-coxsackievirus agents. Bioorg. Med. Chem. Lett. 2017;274:829&#x2013;833. doi: 10.1016/j.bmcl.2017.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2017.01.022</ArticleId><ArticleId IdType="pubmed">28109785</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhai X., Qin Y., Chen Y., Lin L., Wang T., Zhong X., Wu X., Chen S., Li J., Wang Y., et al. Coxsackievirus B3 induces the formation of autophagosomes in cardiac fibroblasts both in vitro and in vivo. Exp. Cell Res. 2016;349:255&#x2013;263. doi: 10.1016/j.yexcr.2016.10.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2016.10.020</ArticleId><ArticleId IdType="pubmed">27793649</ArticleId></ArticleIdList></Reference><Reference><Citation>Feld J.J., Jacobson I.M., Sulkowski M.S., Poordad F., Tatsch F., Pawlotsky J.M. Ribavirin Revisited in the Era of Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection. Liver Int. 2017;37:5&#x2013;18. doi: 10.1111/liv.13212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/liv.13212</ArticleId><ArticleId IdType="pmc">PMC5216450</ArticleId><ArticleId IdType="pubmed">27473533</ArticleId></ArticleIdList></Reference><Reference><Citation>Markland W., McQuaid T.J., Jain J., Kwong A.D. Broadspectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497&#x2014;a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon. Antimicrob. Agents Chemother. 2000;44:859&#x2013;866. doi: 10.1128/AAC.44.4.859-866.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/AAC.44.4.859-866.2000</ArticleId><ArticleId IdType="pmc">PMC89783</ArticleId><ArticleId IdType="pubmed">10722482</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning Q., Brown D., Parodo J., Cattral M., Gorczynski R., Cole E., Fung L., Ding J.W., Rotstein O., Phillips M.J., et al. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulate fg12 prothrombinase and preserves the Thi cytokines production but inhibits Th2 cytokines response. J. Immunol. 1998;160:3487&#x2013;3493.</Citation><ArticleIdList><ArticleId IdType="pubmed">9531310</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty S., Cameron C.E., Andion R. RNA virus error catastrophe: Direct molecular test by using ribavirin. PNAS. 2001;98:6895&#x2013;6900. doi: 10.1073/pnas.111085598.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.111085598</ArticleId><ArticleId IdType="pmc">PMC34449</ArticleId><ArticleId IdType="pubmed">11371613</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 1938;27:493&#x2013;497.</Citation></Reference><Reference><Citation>Kumar P., Nagarajan A., Uchil P.D. Analysis of Cell Viability by the MTT Assay. Cold Spring Harb Protoc. 2018;6:pdb-prot095505. doi: 10.1101/pdb.prot095505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/pdb.prot095505</ArticleId><ArticleId IdType="pubmed">29858338</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>